Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms
2 Ansichten
• 07/29/23
0
0
Einbetten
administrator
Abonnenten
Naveen Pemmaraju, MD, discusses the need to move beyond JAK inhibition when treating patients with myeloproliferative neoplasms.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare